The use of immunosuppressive agents in the treatment of multiple sclerosis: A critical review

Neurology

Volumn 41, Issue 7, 1991, Pages 980-985

  Goodin, Douglas S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; CYCLOPHOSPHAMIDE; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; PREDNISONE;

HUMAN; MAJOR CLINICAL STUDY; MULTIPLE SCLEROSIS; PLASMAPHERESIS; PRIORITY JOURNAL; REVIEW;

ADRENAL CORTEX HORMONES; CLINICAL TRIALS; COMPARATIVE STUDY; CYCLOPHOSPHAMIDE; HUMAN; IMMUNOSUPPRESSIVE AGENTS; LIFE TABLES; MULTIPLE SCLEROSIS; PLASMA EXCHANGE; STATISTICS;

EID: 0026047769     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/wnl.41.7.980     Document Type: Review

References (23)

1. Rationale for immunomodulating therapies of multiple sclerosis. Neurology 1988;38(suppl 2):1-89.
2. Willoughby EW, Paty DW. Scales for rating impairment in multiple sclerosis: a critique. Neurology 1988;38:1793-1798.
3. Noseworthy JH, Vandervoort MK, Wong CJ, Ebers GC, Canadian Cooperative MS Study Group. Interrater variability with the expanded disability status scale (EDSS) and functional systems (FS) in a multiple sclerosis clinical trial. Neurology 1990;40:971-975.
4. Hauser SL, Dawson DM, Lehrich JR, et al. Intensive immunosuppression in progressive multiple sclerosis: a randomized, three-arm study of high-dose intravenous cyclophosphamide, plasma exchange, and ACTH. N Engl J Med 1983;308:173-180.
5. Likosky WH. Experience with cyclophosphamide in multiple sclerosis: the cons. Neurology 1988;38(suppl 2):14-18.
6. Cooperative study in the evaluation of therapy in multiple sclerosis: ACTH vs. placebo—final report Neurology 1970;20(part 2):1-59.
7. Ott L, Larson RF, Mendenhall W. Statistics: a tool for the social sciences. Boston: Prindle, Weber and Schmidt, 1987.
8. Khatri BO, McQuillen MP, Harrington GJ, Schmoll D, Hoffmann RG. Chronic progressive multiple sclerosis: double-blind controlled study of plasmapheresis in patients taking immunosuppressive drugs. Neurology 1985;35:312-319.
9. Goodkin DE, Plencner S, Palmer-Saxerud J, Teetzen M, Hertsgaard D. Cyclophosphamide in chronic progressive multiple sclerosis. Arch Neurol 1987;44:823-827.
10. Koopmans LA. Introduction to contemporary statistical methods. Boston: Prindle, Weber and Schmidt, 1987.
11. Weiner HL, Dau PC, Khatri BO, et al. Double-blind study of true vs. sham plasma exchange in patients treated with immunosuppression for acute attacks of multiple sclerosis. Neurology 1989;39:1143-1149.
12. Khatri BO, D’Cruz O, Priesler G, Hambrook G, Worthington D. Plasmapheresis in a pregnant patient with multiple sclerosis. Arch Neurol 1990;47:11-12.
13. Masland R. Cooperative study in the evaluation of therapy in multiple sclerosis: ACTH vs. placebo in acute exacerbation (Discussion). Trans Am Neurol Assoc 1969;94:131-132.
14. Peto R, Pike MC, Armitage P, et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. Br J Cancer 1977;35:1-39.
15. Lee ET. Statistical methods for survival data analysis. Belmont, CA: Lifetime Learning Publications, 1980.
16. Snead OC, Benton JW, Myers GJ. ACTH and prednisone in childhood seizure disorders. Neurology 1983;33:966-970.
17. Barnes MP, Bateman DE, Cleland PG, et al. Intravenous methyl-prednisolone for multiple sclerosis in relapse. J Neurol Neurosurg Psychiatry 1985;48:157-159.
18. Durelli L, Cocito D, Riccio A, et al. High-dose intravenous methyl-prednisolone in the treatment of multiple sclerosis: clinical-immunologic correlations. Neurology 1986;36:238-243.
19. Ohno R, Hamaguchi K, Sowa K, Tanaka H, Watanabe Y. Highdose intravenous corticosteroids in the treatment of multiple sclerosis. Jpn J Med 1987;26:212-216.
20. Milligan NM, Newcombe R, Compston DAS. A double-blind controlled trial of high dose methylprednisolone in patients with multiple sclerosis: 1. Clinical effects. J Neurol Neurosurg Psychiatry 1987;50:511-516.
21. Thompson AJ, Kennard C, Swash M, et al. Relative efficacy of intravenous methylprednisolone and ACTH in the treatment of acute relapse in MS. Neurology 1989;39:969-971.
22. Killian JM, Bressler RB, Armstrong RM, Huston DP. Controlled pilot trial of monthly intravenous cyclophosphamide in multiple sclerosis. Arch Neurol 1988;45:27-30.
23. Berger JR, Sheremata WA, Resnick L, Atherton S, Fletcher MA, Noren-berg M. Multiple sclerosis-like illness occurring with human immunodeficiency virus infection. Neurology 1989;39:324-329.